Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-07038124 in Seborrheic Dermatitis and Papulopustular Rosacea
NCT06013371Phase 2Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2023
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PF-07038124 in seborrheic dermatitis (SD), papulopustular rosacea, sponsored by Icahn School of Medicine at Mount Sinai. Started Jul 2023; status: terminated.
02
Drugs
PF-07038124
03
Conditions
seborrheic dermatitis (SD)papulopustular rosacea
Beyond the preview
Go deeper on NCT06013371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06013371.